InterleuKin-33 And Interferon-Γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation During Immune Perturbation

Immunity

Volumn 43, Issue 1, 2015, Pages 161-174

  Molofsky, Ari B ^b   Van Gool, Frédéric ^a   Liang, Hong Erh ^a   Van Dyken, Steven J ^a,b   Nussbaum, Jesse C ^b   Lee, Jinwoo ^b   Bluestone, Jeffrey A ^a,b   Locksley, Richard M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INDUCIBLE T CELL COSTIMULATOR; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 27; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; MYELOID DIFFERENTIATION FACTOR 88; IL33 PROTEIN, MOUSE; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN DERIVATIVE; KLRG1 PROTEIN, MOUSE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL EXPANSION; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EOSINOPHIL; GROUP 2 INNATE LYMPHOID CELL; HELMINTHIASIS; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INTRAABDOMINAL FAT; LIPID DIET; LYMPHOID CELL; MOUSE; NATURAL KILLER CELL; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PARASITE CLEARANCE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH2 CELL; ANIMAL; BIOSYNTHESIS; CYTOLOGY; ENZYME ACTIVATION; IMMUNOLOGY; LISTERIA MONOCYTOGENES; LISTERIOSIS; LUNG; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; NIPPOSTRONGYLUS; OBESITY; PARASITOLOGY; PATHOLOGY; STRONGYLE INFECTION; TRANSGENIC MOUSE;

AGING; ANIMALS; DIET, HIGH-FAT; ENZYME ACTIVATION; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-33; INTERLEUKINS; INTRA-ABDOMINAL FAT; LISTERIA MONOCYTOGENES; LISTERIOSIS; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; NIPPOSTRONGYLUS; OBESITY; RECEPTORS, IMMUNOLOGIC; STRONGYLIDA INFECTIONS; T-LYMPHOCYTES, REGULATORY;

EID: 84937618997     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2015.05.019     Document Type: Article

References (65)

1. Allen J.E., Maizels R.M. Diversity and dialogue in immunity to helminths. Nat. Rev. Immunol. 2011, 11:375-388.
2. Brestoff J.R., Kim B.S., Saenz S.A., Stine R.R., Monticelli L.A., Sonnenberg G.F., Thome J.J., Farber D.L., Lutfy K., Seale P., et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 2014, 519:1-17.
3. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
4. Brunner S.M., Schiechl G., Falk W., Schlitt H.J., Geissler E.K., Fichtner-Feigl S. Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl. Int. 2011, 24:1027-1039.
5. Burzyn D., Benoist C., Mathis D. Regulatory Tcells in nonlymphoid tissues. Nat. Immunol. 2013, 14:1007-1013.
6. Burzyn D., Kuswanto W., Kolodin D., Shadrach J.L., Cerletti M., Jang Y., Sefik E., Tan T.G., Wagers A.J., Benoist C., Mathis D. A special population of regulatory Tcells potentiates muscle repair. Cell 2013, 155:1282-1295.
7. Busse M., Krech M., Meyer-Bahlburg A., Hennig C., Hansen G. ICOS mediates the generation and function of CD4+CD25+Foxp3+ regulatory Tcells conveying respiratory tolerance. J.Immunol. 2012, 189:1975-1982.
8. Cayrol C., Girard J.-P. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 2014, 31:31-37.
9. Chaudhry A., Rudensky A.Y. Control of inflammation by integration of environmental cues by regulatory Tcells. J.Clin. Invest. 2013, 123:939-944.
10. Cheng G., Yuan X., Tsai M.S., Podack E.R., Yu A., Malek T.R. IL-2 receptor signaling is essential for the development of Klrg1+ terminally differentiated T regulatory cells. J.Immunol. 2012, 189:1780-1791.
11. Cipolletta D., Feuerer M., Li A., Kamei N., Lee J., Shoelson S.E., Benoist C., Mathis D. PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 2012, 486:549-553.
12. Coyle, A.J., Tsuyuki, S., Bertrand, C., Huang, S., Aguet, M., Alkan, S.S., and Anderson, G.P. (1996). Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of Tcells to exhibit a Th2 cytokine profile. 156, 2680-2685.
13. + regulatory T-cell responses in mice. Mol. Med. 2012, 18:753-761.
14. Feuerer M., Herrero L., Cipolletta D., Naaz A., Wong J., Nayer A., Lee J., Goldfine A.B., Benoist C., Shoelson S., Mathis D. Lean, but not obese, fat is enriched for a unique population of regulatory Tcells that affect metabolic parameters. Nat. Med. 2009, 15:930-939.
15. Feuerer M., Hill J.A., Kretschmer K., von Boehmer H., Mathis D., Benoist C. Genomic definition of multiple exvivo regulatory Tcell subphenotypes. Proc. Natl. Acad. Sci. USA 2010, 107:5919-5924.
16. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory Tcells. Nat. Immunol. 2003, 4:330-336.
17. Gadani S.P., Walsh J.T., Smirnov I., Zheng J., Kipnis J. The glia-derived alarmin IL-33 orchestrates the immune response and promotes recovery following CNS injury. Neuron 2015, 85:703-709.
18. Hepworth M.R., Monticelli L.A., Fung T.C., Ziegler C.G.K., Grunberg S., Sinha R., Mantegazza A.R., Ma H.-L., Crawford A., Angelosanto J.M., et al. Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 2013, 498:113-117.
19. Heredia J.E., Mukundan L., Chen F.M., Mueller A.A., Deo R.C., Locksley R.M., Rando T.A., Chawla A. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 2013, 153:376-388.
20. Hussaarts L., Garcia-Tardon N., van Beek L., Heemskerk M.M., Haeberlein S., van der Zon G.C., Ozir-Fazalalikhan A., Berbee J.F.P., Willems van Dijk K., van Harmelen V., et al. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice. Faseb J. 2015, fj.14-fj.266239.
21. Johnston C.J.C., McSorley H.J., Anderton S.M., Wigmore S.J., Maizels R.M. Helminths and immunological tolerance. Transplantation 2014, 97:127-132.
22. Lee M.-W., Odegaard J.I., Mukundan L., Qiu Y., Molofsky A.B., Nussbaum J.C., Yun K., Locksley R.M., Chawla A. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell 2015, 160:74-87.
23. Liang Y., Jie Z., Hou L., Aguilar-Valenzuela R., Vu D., Soong L., Sun J. IL-33 induces nuocytes and modulates liver injury in viral hepatitis. J.Immunol. 2013, 190:5666-5675.
24. Liao W., Lin J.-X., Leonard W.J. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 2011, 23:598-604.
25. Lynch L., Michelet X., Zhang S., Brennan P.J., Moseman A., Lester C., Besra G., Vomhof-Dekrey E.E., Tighe M., Koay H.-F., et al. Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue. Nat. Immunol. 2015, 16:85-95.
26. Maazi H., Patel N., Sankaranarayanan I., Suzuki Y., Rigas D., Soroosh P., Freeman G.J., Sharpe A.H., Akbari O. ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 2015, 42:538-551.
27. McSorley H.J., Maizels R.M. Helminth infections and host immune regulation. Clin. Microbiol. Rev. 2012, 25:585-608.
28. Miller A.M., Xu D., Asquith D.L., Denby L., Li Y., Sattar N., Baker A.H., McInnes I.B., Liew F.Y. IL-33 reduces the development of atherosclerosis. J.Exp. Med. 2008, 205:339-346.
29. Miller A.M., Asquith D.L., Hueber A.J., Anderson L.A., Holmes W.M., McKenzie A.N., Xu D., Sattar N., McInnes I.B., Liew F.Y. Interleukin-33 induces protective effects in adipose tissue inflammation during obesity in mice. Circ. Res. 2010, 107:650-658.
30. Molofsky A.B., Nussbaum J.C., Liang H.-E., Van Dyken S.J., Cheng L.E., Mohapatra A., Chawla A., Locksley R.M. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J.Exp. Med. 2013, 210:535-549.
31. Moro K., Yamada T., Tanabe M., Takeuchi T., Ikawa T., Kawamoto H., Furusawa J., Ohtani M., Fujii H., Koyasu S. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
32. Neill D.R., Wong S.H., Bellosi A., Flynn R.J., Daly M., Langford T.K.A., Bucks C., Kane C.M., Fallon P.G., Pannell R., et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
33. Nishimura S., Manabe I., Nagasaki M., Eto K., Yamashita H., Ohsugi M., Otsu M., Hara K., Ueki K., Sugiura S., et al. CD8+ effector Tcells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 2009, 15:914-920.
34. Nussbaum J.C., Van Dyken S.J., von Moltke J., Cheng L.E., Mohapatra A., Molofsky A.B., Thornton E.E., Krummel M.F., Chawla A., Liang H.-E., Locksley R.M. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013, 502:245-248.
35. Odegaard J.I., Ricardo-Gonzalez R.R., Goforth M.H., Morel C.R., Subramanian V., Mukundan L., Red Eagle A., Vats D., Brombacher F., Ferrante A.W., Chawla A. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 2007, 447:1116-1120.
36. Oliphant C.J., Hwang Y.Y., Walker J.A., Salimi M., Wong S.H., Brewer J.M., Englezakis A., Barlow J.L., Hams E., Scanlon S.T., et al. MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) Tcells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 2014, 41:283-295.
37. Pichery M., Mirey E., Mercier P., Lefrancais E., Dujardin A., Ortega N., Girard J.-P. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: insitu analysis using a novel Il-33-LacZ gene trap reporter strain. J.Immunol. 2012, 188:3488-3495.
38. Price A.E., Reinhardt R.L., Liang H.-E., Locksley R.M. Marking and quantifying IL-17A-producing cells invivo. PLoS ONE 2012, 7:e39750.
39. Qiu Y., Nguyen K.D., Odegaard J.I., Cui X., Tian X., Locksley R.M., Palmiter R.D., Chawla A. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014, 157:1292-1308.
40. Redpath S.A., van der Werf N., Cervera A.M., MacDonald A.S., Gray D., Maizels R.M., Taylor M.D. ICOS controls Foxp3(+) regulatory T-cell expansion, maintenance and IL-10 production during helminth infection. Eur. J. Immunol. 2013, 43:705-715.
41. Reinhardt, R.L., Liang, H.-E., Bao, K., Price, A.E., Mohrs, M., Ben L Kelly, and Locksley, R.M. (2015). A Novel Model for IFN-γ-Mediated Autoinflammatory Syndromes. 1401992.
42. Reinhold U., Kukel S., Brzoska J., Kreysel H.W. Systemic interferon gamma treatment in severe atopic dermatitis. J.Am. Acad. Dermatol. 1993, 29:58-63.
43. Robinette M.L., Fuchs A., Cortez V.S., Lee J.S., Wang Y., Durum S.K., Gilfillan S., Colonna M., Shaw L., Yu B., et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 2015, 16:306-317. Immunological Genome Consortium.
44. Schiering C., Krausgruber T., Chomka A., Fröhlich A., Adelmann K., Wohlfert E.A., Pott J., Griseri T., Bollrath J., Hegazy A.N., et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 2014, 513:564-568.
45. Sim G.C., Martin-Orozco N., Jin L., Yang Y., Wu S., Washington E., Sanders D., Lacey C., Wang Y., Vence L., et al. IL-2 therapy promotes suppressive ICOS+ Treg expansion in melanoma patients. J.Clin. Invest. 2014, 124:99-110.
46. Smigiel K.S., Richards E., Srivastava S., Thomas K.R., Dudda J.C., Klonowski K.D., Campbell D.J. CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory Tcell subsets. J.Exp. Med. 2014, 211:121-136.
47. Stetson D.B., Mohrs M., Reinhardt R.L., Baron J.L., Wang Z.-E., Gapin L., Kronenberg M., Locksley R.M. Constitutive cytokine mRNAs mark natural killer (NK) and NK Tcells poised for rapid effector function. J.Exp. Med. 2003, 198:1069-1076.
48. Stolarczyk E., Vong C.T., Perucha E., Jackson I., Cawthorne M.A., Wargent E.T., Powell N., Canavan J.B., Lord G.M., Howard J.K. Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell Metab. 2013, 17:520-533.
49. Turnquist H.R., Zhao Z., Rosborough B.R., Liu Q., Castellaneta A., Isse K., Wang Z., Lang M., Stolz D.B., Zheng X.X., et al. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory Tcells, including ST2L+ Foxp3+ cells, and mediates regulatory Tcell-dependent promotion of cardiac allograft survival. J.Immunol. 2011, 187:4598-4610.
50. Van Gool F., Molofsky A.B., Morar M.M., Rosenzwajg M., Liang H.-E., Klatzmann D., Locksley R.M., Bluestone J.A. Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy. Blood 2014, 124:3572-3576.
51. Vasanthakumar A., Moro K., Xin A., Liao Y., Gloury R., Kawamoto S., Fagarasan S., Mielke L.A., Afshar-Sterle S., Masters S.L., et al. The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory Tcells. Nat. Immunol. 2015, Published January 19, 2015. 10.1038/ni.3085.
52. Voehringer D., Reese T.A., Huang X., Shinkai K., Locksley R.M. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J.Exp. Med. 2006, 203:1435-1446.
53. Walker J.A., McKenzie A.N. Development and function of group 2 innate lymphoid cells. Curr. Opin. Immunol. 2013, 25:148-155.
54. Wang Y., Su M.A., Wan Y.Y. An essential role of the transcription factor GATA-3 for the function of regulatory Tcells. Immunity 2011, 35:337-348.
55. Wensveen F.M., Jelenčić V., Valentić S., Šestan M., Wensveen T.T., Theurich S., Glasner A., Mendrila D., Štimac D., Wunderlich F.T., et al. NK cells link obesity-induced adipose stress to inflammation and insulin resistance. Nat. Immunol. 2015, 16:376-385.
56. Winer S., Chan Y., Paltser G., Truong D., Tsui H., Bahrami J., Dorfman R., Wang Y., Zielenski J., Mastronardi F., et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 2009, 15:921-929.
57. Wiria A.E., Sartono E., Supali T., Yazdanbakhsh M. Helminth infections, type-2 immune response, and metabolic syndrome. PLoS Pathog. 2014, 10:e1004140.
58. + regulatory Tcell fate during inflammation in mice. J.Clin. Invest. 2011, 121:4503-4515.
59. Wood P.M.D., Fieschi C., Picard C., Ottenhoff T.H.M., Casanova J.-L., Kumararatne D.S. Inherited defects in the interferon-gamma receptor or interleukin-12 signalling pathways are not sufficient to cause allergic disease in children. Eur. J. Pediatr. 2005, 164:741-747.
60. Wood I.S., Wang B., Trayhurn P. IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem. Biophys. Res. Commun. 2009, 384:105-109.
61. Wu D., Molofsky A.B., Liang H.-E., Ricardo-Gonzalez R.R., Jouihan H.A., Bando J.K., Chawla A., Locksley R.M. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
62. Yang Z., Grinchuk V., Smith A., Qin B., Bohl J.A., Sun R., Notari L., Zhang Z., Sesaki H., Urban J.F., et al. Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. Infect. Immun. 2013, 81:1905-1914.
63. Yin H., Li X., Hu S., Liu T., Yuan B., Gu H., Ni Q., Zhang X., Zheng F. IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages. Mol. Immunol. 2013, 56:347-353.
64. Zeyda M., Wernly B., Demyanets S., Kaun C., Hämmerle M., Hantusch B., Schranz M., Neuhofer A., Itariu B.K., Keck M., et al. Severe obesity increases adipose tissue expression of interleukin-33 and its receptor ST2, both predominantly detectable in endothelial cells of human adipose tissue. Int J Obes 2012, (London).
65. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.-T., Corcoran L., Treuting P., Klein U., Rudensky A.Y. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.